Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.

Authors :: Allan, J. M.
Sunter, N. J.
Bailey, J. R.
Pettitt, A. R.
Harris, R. J.
Pepper, C.
Fegan, C.
Hall, A. G.
Deignan, L.
Bacon, C. M.
Pointon, J. C.
Houlston, R. S.
Broderick, P.
Mainou-Fowler, T.
Jackson, G. H.
Summerfield, G.
Evans, P. A.
Strefford, J. C.
Parker, A.
Oscier, D.
Source :: Leukemia (08876924); Apr2010, Vol. 24 Issue 4, p877-881, 5p, 3 Charts, 1 Graph
Publication Year :: 2010
Abstract: A letter to the editor is presented related to the treatment of chronic lymphocytic leukemia (CLL).

Full Text Access

Tools